These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9802941)

  • 41. Expression of antibody Fab fragments and whole immunoglobulin in mammalian cells.
    Sanna PP
    Methods Mol Biol; 2002; 178():389-95. PubMed ID: 11968508
    [No Abstract]   [Full Text] [Related]  

  • 42. Zipbodyzyme: Development of new antibody-enzyme fusion proteins.
    Mori A; Ojima-Kato T; Kojima T; Nakano H
    J Biosci Bioeng; 2018 Jun; 125(6):637-643. PubMed ID: 29398551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell-free synthesis of functional and endotoxin-free antibody Fab fragments by translocation into microsomes.
    Merk H; Gless C; Maertens B; Gerrits M; Stiege W
    Biotechniques; 2012 Sep; 53(3):153-60. PubMed ID: 22963477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Engineering and characterization of the chimeric antibody that targets the C-terminal telopeptide of the α2 chain of human collagen I: a next step in the quest to reduce localized fibrosis.
    Fertala J; Steplewski A; Kostas J; Beredjiklian P; Williams G; Arnold W; Abboud J; Bhardwaj A; Hou C; Fertala A
    Connect Tissue Res; 2013; 54(3):187-96. PubMed ID: 23586407
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a human IgA antibody specific for the tumour antigen TAG-72.
    Ingram PE; Owens RJ; Woof JM
    Biochem Soc Trans; 1997 May; 25(2):330S. PubMed ID: 9191375
    [No Abstract]   [Full Text] [Related]  

  • 46. Simple scale-up of recombinant antibody production using an UCOE containing vector.
    Boscolo S; Mion F; Licciulli M; Macor P; De Maso L; Brce M; Antoniou MN; Marzari R; Santoro C; Sblattero D
    N Biotechnol; 2012 May; 29(4):477-84. PubMed ID: 22226921
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Re-engineering and evaluation of anti-DNA autoantibody 3E10 for therapeutic applications.
    Rattray Z; Dubljevic V; Rattray NJW; Greenwood DL; Johnson CH; Campbell JA; Hansen JE
    Biochem Biophys Res Commun; 2018 Feb; 496(3):858-864. PubMed ID: 29374508
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Spontaneous antinuclear antibodies in mice with or without pathologic lesions].
    Monier JC; Thivolet J; Sepetjian M
    Ann Inst Pasteur (Paris); 1969 May; 116(5):646-56. PubMed ID: 4890438
    [No Abstract]   [Full Text] [Related]  

  • 49. Central Nervous System Delivery and Biodistribution Analysis of an Antibody-Enzyme Fusion for the Treatment of Lafora Disease.
    Austin GL; Simmons ZR; Klier JE; Rondon A; Hodges BL; Shaffer R; Aziz NM; McKnight TR; Pauly JR; Armstrong DD; Vander Kooi CW; Gentry MS
    Mol Pharm; 2019 Sep; 16(9):3791-3801. PubMed ID: 31329461
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rapid establishment of myeloma cell lines expressing Fab(Tac)-protamine, a targetable protein vector, directed against high-affinity alpha-chain of human interleukin-2 receptor.
    Song SU; Marasco WA
    Methods Mol Biol; 2000; 133():157-66. PubMed ID: 10561837
    [No Abstract]   [Full Text] [Related]  

  • 51. Novel protein transfection of primary rat cortical neurons using an antibody that penetrates living cells.
    Weisbart RH; Baldwin R; Huh B; Zack DJ; Nishimura R
    J Immunol; 2000 Jun; 164(11):6020-6. PubMed ID: 10820286
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimization of Mouse-on-Mouse Immunohistochemistry by Utilizing Fluorescent-dye Conjugated Secondary Anti-Mouse Antibody.
    Moein S; Adibi R; Amouheidari A; Gheisari Y
    Appl Immunohistochem Mol Morphol; 2021 Jul; 29(6):473-477. PubMed ID: 33958524
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tagging potassium ion channels with green fluorescent protein to study mobility and interactions with other proteins.
    Levitan ES
    Methods Enzymol; 1999; 294():47-58. PubMed ID: 9916222
    [No Abstract]   [Full Text] [Related]  

  • 54. Chimerization of multiple antibody classes using splice overlap extension PCR.
    Jones ML; Barnard RT
    Biotechniques; 2005 Feb; 38(2):181-2. PubMed ID: 15727121
    [No Abstract]   [Full Text] [Related]  

  • 55. [Cell nucleus reactions during analysis of antinuclear factors with the immunofluorescence technic].
    Bäumer A; Brinkmann A
    Z Rheumaforsch; 1970; 29(11):358-65. PubMed ID: 5313187
    [No Abstract]   [Full Text] [Related]  

  • 56. Electroporation of Labeled Antibodies to Visualize Endogenous Proteins and Posttranslational Modifications in Living Metazoan Cell Types.
    Conic S; Desplancq D; Tora L; Weiss E
    Bio Protoc; 2018 Nov; 8(21):. PubMed ID: 30467550
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antinuclear antibodies: to penetrate or not to penetrate, that was the question.
    Alarcón-Segovia D
    Lupus; 2001; 10(5):315-8. PubMed ID: 11403260
    [No Abstract]   [Full Text] [Related]  

  • 58. [Drug discovery using modified-monoclonal antibody technologies].
    Yamakawa A; Iwata S
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():408-12. PubMed ID: 23513875
    [No Abstract]   [Full Text] [Related]  

  • 59. Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition.
    Rackear M; Quijano E; Ianniello Z; Colón-Ríos DA; Krysztofiak A; Abdullah R; Liu Y; Rogers FA; Ludwig DL; Dwivedi R; Bleichert F; Glazer PM
    Oncotarget; 2024 Oct; 15():699-713. PubMed ID: 39352803
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting RAD51-Mediated Homologous Recombination as a Treatment for Advanced Solid and Hematologic Malignancies: Opportunities and Challenges Ahead.
    Tsang ES; Munster PN
    Onco Targets Ther; 2022; 15():1509-1518. PubMed ID: 36536949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.